Publicacions - FIDMAG, Fundació per a la recerca

Inici
> Recerca

Filtre

Resultat: 10 articles / Factor Impacte: 114.48

FI
1.976

2022 Lancet PsychiatryRelapse prevention in schizophrenia.Jauhar S, Laws K, Fusar-Poli P, McKenna P

FI
3.525

2022 European Archives Of Psychiatry And Clinical NeuroscienceCompleted suicide is associated with a higher polygenic burden for psychiatric disorders.Mitjans M, Papiol S, Barrot C, Guardiola-Ripoll M, Giménez-Palomo A, Gavín P, Oraki Kohshour M, Acosta M, Pomarol-Clotet E, Castellà-García J, Pérez-Pérez RM, Gutiérrez B, Schulze TG, Fatjó-Vilas M, Arias B, Benabarre A

FI
5

2022 Nature partner journals schizophreniaCortical thinning over two years after first-episode psychosis depends on age of onset.Pina-Camacho L, Martinez K, Diaz-Caneja CM, Mezquida G, Cuesta MJ, Moreno C, Amoretti S, González-Pinto A, Arango C, Vieta E, Castro-Fornieles J, Lobo A, Fraguas D, Bernardo M, Janssen J, Parellada M

FI
2

2022 Journal of reproductive and infant psychologyThe COVID-19 Pandemic and Psychopathological symptoms in pregnant women in Spain.Garcia-Leon MA, Martin-Tortosa PL, Cambio-Ledesma A, Caparros-Gonzalez RA

FI
3.923

2022 Schizophrenia ResearchClinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia.Bioque M, Mezquida G, Amoretti S, García-Rizo C, López-Ilundain JM, Diaz-Caneja CM, Zorrilla I, Mané A, Rodriguez-Jimenez R, Corripio I, Pomarol-Clotet E, Ibáñez Á, Usall J, Contreras F, Mas S, Vázquez-Bourgon J, Cuesta MJ, Parellada M, González-Pinto A, Hidalgo-Figueroa M, Bernardo M

FI
4.369

2022 European NeuropsychopharmacologyThe role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study.Martínez-Pinteño A, Mezquida G, Bioque M, López-Ilundain JM, Andreu-Bernabeu Á, Zorrilla I, Mané A, Rodríguez-Jiménez R, Corripio I, Sarró S, Ibáñez Á, Usall J, Rivero O, Gassó P, Leza JC, Cuesta MJ, Parellada M, González-Pinto A, Berrocoso E, Mas S, Bernardo M

FI
3.875

2022 PsychopharmacologyStriatal dopamine synthesis capacity and its association with negative symptoms upon resolution of positive symptoms in first-episode schizophrenia and delusional disorder.Wong SMY, Suen YN, Wong CWC, Chan SKW, Hui CLM, Chang WC, Lee EHM, Cheng CPW, Ho GCL, Lo GG, Leung EYL, Yeung PKMA, Chen S, Honer WG, Mak HKF, Sham PC, McKenna PJ, Pomarol-Clotet E, Veronese M, Howes OD, Chen EYH

FI
5.605

2022 Acta Psychiatrica ScandinavicaProdromal phase: Differences in prodromal symptoms, risk factors and markers of vulnerability in first episode mania versus first episode psychosis with onset in late adolescence or adulthood.Verdolini N, Borràs R, Sparacino G, Garriga M, Sagué-Vilavella M, Madero S, Palacios-Garrán R, Serra M, Forte MF, Salagre E, Aedo A, Salgado-Pineda P, Salvatierra IM, Sánchez Gistau V, Pomarol-Clotet E, Ramos-Quiroga JA, Carvalho AF, Garcia-Rizo C, Undurraga J, Reinares M, Martinez Aran A, Bernardo M, Vieta E, Pacchiarotti I, Amoretti S

FI
79.323

2022 LancetSchizophrenia.Jauhar S, Johnstone M, McKenna PJ

FI
4.881

2022 NeuroImage-ClinicalAltered brain responses to specific negative emotions in schizophrenia.Garcia-Leon MA, Fuentes-Claramonte P, Valiente-Gómez A, Natividad C, Salgado-Pineda P, Gomar JJ, Guerrero-Pedraza A, Portillo F, Ortiz-Gil J, Alonso-Lana S, Maristany T, Raduà J, Salvador R, Sarró S, Pomarol-Clotet E